Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy

Practical Radiation Oncology

Volumn 2, Issue 1, 2012, Pages 46-53

  Oku, Yohei ^a   Takeda, Atsuya ^a   Kunieda, Etsuo ^b   Sudo, Yasunobu ^a   Oooka, Yoshikazu ^a   Aoki, Yousuke ^a   Shimouchi, Yoshiaki ^a   Nishina, Ryohei ^a   Nomura, Kazuhiro ^a   Sugiura, Madoka ^a   Ohashi, Toshio ^a,c  

^a Ofuna Chuo Hospital   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DOSIMETRY; DYNAMIC CONFORMAL MULTIPLE ARC THERAPY; HUMAN; ISODOSE; LUNG TUMOR; PLANNING TARGET VOLUME; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOLOGICAL PARAMETERS; RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR VOLUME;

EID: 84155167805     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2011.06.001     Document Type: Article

References (28)

1. Videtic G.M., Stephans K., Reddy C., et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys 2010, 77:344-349.
2. Holt A, van Vliet-Vroegindeweij C, Mans A, Belderbos JS, Damen EM. Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques [published online ahead of print February 5, 2011]. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.09.014.
3. Takeda A., Kunieda E., Sanuki N., et al. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys 2009, 74:363-369.
4. Takeda A., Kunieda E., Shigematsu N., et al. Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-initial findings. Radiology 2005, 237:295-300.
5. Miften M., Wiesmeyer M., Monthofer S., Krippner K. Implementation of FFT convolution and multigrid superposition models in the FOCUS RTP system. Phys Med Biol 2000, 45:817-833.
6. Buyyounouski M.K., Balter P., Lewis B., et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys 2010, 78:3-10.
7. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998, 42:1-9.
8. Van Dyk J., Mah K., Keane T.J. Radiation-induced lung damage: dose-time-fractionation considerations. Radiother Oncol 1989, 14:55-69.
9. Paludan M., Traberg Hansen A., Petersen J., Grau C., Høyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?. Acta Oncol 2006, 45:818-822.
10. Fujino M., Shirato H., Onishi H., et al. Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J 2006, 12:41-46.
11. Kimura T., Matsuura K., Murakami Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?. Int J Radiat Oncol Biol Phys 2006, 66:483-491.
12. Ma L. Dependence of normal brain integral dose and normal tissue complication probability on the prescription isodose values for gamma-knife radiosurgery. Phys Med Biol 2001, 46:3031-3041.
13. Nagata Y., Matsuo Y., Takayama K., et al. Current status of stereotactic body radiotherapy for lung cancer. Int J Clin Oncol 2007, 12:3-7.
14. Matsuo Y., Takayama K., Nagata Y., et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2007, 68:416-425.
15. Søvik A., Malinen E., Olsen D.R. Strategies for biologic image-guided dose escalation: a review. Int J Radiat Oncol Biol Phys 2009, 73:650-658.
16. Bentzen S.M., Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol 2011, 21:101-110.
17. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001, 49:1171-1182.
18. Craig J.R., Peters R.L., Edmondson H.A. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology 1988, 256-267. Armed Forces Institute of Pathology, Washington. 2nd ed. W.H. Hartmann, L.H. Sobin (Eds.).
19. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899.
20. Bristow R.G., Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008, 8:180-192.
21. Brown J.M. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 2002, 1:453-458.
22. Pettersson N., Nyman J., Johansson K.A. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. Radiother Oncol 2009, 91:360-368.
23. Dunlap N.E., Cai J., Biedermann G.B., et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:796-801.
24. Ng A.W.Y., Tung S.Y., Wong V.Y.W. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs. Radiother Oncol 2008, 87:24-28.
25. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000, 48:1015-1024.
26. Timmerman R., Galvin J., Michalski J., et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol 2006, 45:779-786.
27. Hiraoka M., Ishikura S. A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2007, 2(7 suppl 3):S115-S117.
28. Nakaguchi Y., Araki F., Maruyama M., Fukuda S. Comparison of RTPS and Monte Carlo dose distributions in heterogeneous phantoms for photon beams. Nippon Hoshasen Gijutsu Gakkai Zasshi 2010, 66:322-333.